A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses.
Nistor GI, Dillman RO, Robles RM, Langford JL, Poole AJ, Sofro MAU, Nency YM, Jonny J, Yana ML, Karyana M, Lestari ES, Triwardhani R, Mujahidah M, Sari RK, Soetojo NA, Wibisono D, Tjen D, Ikrar T, Sarkissian G, Winarta H, Putranto TA, Keirstead HS.
Nistor GI, et al. Among authors: sari rk.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2100189. doi: 10.1080/21645515.2022.2100189. Epub 2022 Aug 26.
Hum Vaccin Immunother. 2022.
PMID: 36018753
Free PMC article.
Clinical Trial.